Improved economic conditions and increased purchasing power in rural areas contributed to the surge in demand.
Counteroffers must be 5% greater than the anchor offer of Rs 1,220 crore, according to the lenders' requirements.
TML originally issued 'A' Ordinary shares in 2008, followed by another QIP in 2010.
Its profit after tax (PAT) margin increased sequentially by 195 bps to 5.7%, while its EBITDA margin increased sequentially by 97 bps to 21.1%.
The price band for the IPO has been fixed at Rs 285 to Rs 300 per equity share.
Recommendation: Buy; Target price: Rs 1750
Although it climbed by almost 7% YoY to Rs 9,182.31 crore, the total revenue from operations fell short of the expected Rs 9,358 crore.
Consumer prices increased 0.8% in the June quarter, below expectations of 1.0% and the lowest increase since the third quarter of 2021, according to Australian data.
Recommendation: Buy; Target price: Rs 1650
The product is bioequivalent and therapeutically equivalent to the reference-listed medicine, Mozobil Injection, 24 mg/1.2 mL (20 mg/mL) of Genzyme Corporation.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.